Gaochan Wu

1.3k citations

24 papers · 1.1k indexed · h-index 20

Co-authors: Xinyong Liu Dongwei Kang Peng Zhan Lanlan Jing Erik De Clercq Christophe Pannecouque Xiangyi Jiang Zhongxia Zhou
Topics: HIV/AIDS drug development and treatment (16 papers)HIV Research and Treatment (14 papers)Click Chemistry and Applications (11 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Journal of Agricultural and Food Chemistry Journal of Medicinal Chemistry RSC Advances
Partner nations: China Belgium United States

In The Last Decade

Gaochan Wu

24 papers receiving 1.1k citations

Peers

Countries citing papers authored by Gaochan Wu

Since Specialization

Citations

This map shows the geographic impact of Gaochan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaochan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaochan Wu more than expected).

Fields of papers citing papers by Gaochan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaochan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaochan Wu. The network helps show where Gaochan Wu may publish in the future.

Co-authorship network of co-authors of Gaochan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Gaochan Wu. A scholar is included among the top collaborators of Gaochan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaochan Wu. Gaochan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization 2024 ·European Journal of Medicinal Chemistry ·Lanlan Jing,Gaochan Wu,Fabao Zhao,Xiangyi Jiang,Na Liu,Da Feng,Yanying Sun,Tao Zhang,Erik De Clercq,Christophe Pannecouque,Dongwei Kang,(unknown),Peng Zhan	4
2	Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies 2023 ·Bioorganic Chemistry ·Lanlan Jing,(unknown),(unknown),(unknown),Florian Nachon,Ana Martı́nez,Gaochan Wu,(unknown),Yuning Song,Dongwei Kang,Xavier Brazzolotto,Peng Zhan,Xinyong Liu	7
3	Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries 2021 ·Bioorganic Chemistry ·(unknown),Xia Hao,(unknown),Lin Sun,Srinivasulu Cherukupalli,(unknown),Gaochan Wu,Shujing Xu,Xujie Zhang,Xiaoyu Shi,Yuning Song,Xinyong Liu,Peng Zhan	15
4	In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP 2020 ·European Journal of Medicinal Chemistry ·Dongwei Kang,Da Feng,Lanlan Jing,Yanying Sun,Fenju Wei,Xiangyi Jiang,Gaochan Wu,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	27
5	Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors 2019 ·Communications Chemistry ·Dongwei Kang,Tong Zhao,Zhao Wang,Da Feng,Heng Zhang,Boshi Huang,Gaochan Wu,Fenju Wei,Zhongxia Zhou,Lanlan Jing,(unknown),Ye Tian,Vasanthanathan Poongavanam,Jacob Kongsted,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	29
6	Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus 2019 ·Organic & Biomolecular Chemistry ·Zhongxia Zhou,Tao Liu,Gaochan Wu,Dongwei Kang,(unknown),Zhao Wang,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	43
7	Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties 2019 ·Journal of Medicinal Chemistry ·Dongwei Kang,Heng Zhang,Zhao Wang,Tong Zhao,Tiziana Ginex,F. Javier Luque,Yang Yang,Gaochan Wu,Da Feng,Fenju Wei,Jian Zhang,Erik De Clercq,Christophe Pannecouque,Chin Ho Chen,Kuo‐Hsiung Lee,N. Arul Murugan,Thomas A. Steitz,Peng Zhan,Xinyong Liu	75
8	Overview of Recent Strategic Advances in Medicinal Chemistry 2019 ·Journal of Medicinal Chemistry ·Gaochan Wu,Tong Zhao,Dongwei Kang,Jian Zhang,Yuning Song,Vigneshwaran Namasivayam,Jacob Kongsted,Christophe Pannecouque,Erik De Clercq,Vasanthanathan Poongavanam,Xinyong Liu,Peng Zhan	124
9	Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors 2019 ·RSC Advances ·Xiangyi Jiang,Gaochan Wu,Waleed A. Zalloum,Megan E. Meuser,Alexej Dick,Lin Sun,Chin‐Ho Chen,Dongwei Kang,Lanlan Jing,Ruifang Jia,Simon Cocklin,Kuo‐Hsiung Lee,Xinyong Liu,Peng Zhan	53
10	Recent applications of click chemistry in drug discovery 2019 ·Expert Opinion on Drug Discovery ·Xiangyi Jiang,Xia Hao,Lanlan Jing,Gaochan Wu,Dongwei Kang,Xinyong Liu,Peng Zhan	201
11	Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries 2019 ·European Journal of Medicinal Chemistry ·(unknown),Gaochan Wu,Xia Hao,Fisayo A. Olotu,Dongwei Kang,Chin Ho Chen,Kuo‐Hsiung Lee,Mahmoud E. S. Soliman,Xinyong Liu,Yuning Song,Peng Zhan	29
12	Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery 2018 ·ACS Medicinal Chemistry Letters ·Dongwei Kang,Zhao Wang,Heng Zhang,Gaochan Wu,Tong Zhao,Zhongxia Zhou,Zhipeng Huo,Boshi Huang,Da Feng,Xiao Ding,Jian Zhang,(unknown),Lanlan Jing,Wei Luo,(unknown),Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	29
13	Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site 2018 ·ACS Medicinal Chemistry Letters ·Zhipeng Huo,Heng Zhang,Dongwei Kang,Zhongxia Zhou,Gaochan Wu,(unknown),(unknown),Zhao Wang,Lanlan Jing,Xiao Ding,Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	33
14	Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library 2018 ·European Journal of Medicinal Chemistry ·Gaochan Wu,Waleed A. Zalloum,Megan E. Meuser,Lanlan Jing,Dongwei Kang,Chin‐Ho Chen,Ye Tian,Fangfang Zhang,Simon Cocklin,Kuo‐Hsiung Lee,Xinyong Liu,Peng Zhan	55
15	Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors 2018 ·Chemical Biology & Drug Design ·Zhao Wang,Dongwei Kang,Meng Chen,Gaochan Wu,Da Feng,Tong Zhao,Zhongxia Zhou,Zhipeng Huo,Lanlan Jing,(unknown),Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	22
16	Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017) 2018 ·Expert Opinion on Therapeutic Patents ·(unknown),Zhipeng Huo,Dongwei Kang,Gaochan Wu,Zhongxia Zhou,Xinyong Liu,Peng Zhan	33
17	Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors 2017 ·MedChemComm ·Gaochan Wu,Yun Gao,Dongwei Kang,Boshi Huang,Zhipeng Huo,Huiqing Liu,Vasanthanathan Poongavanam,Peng Zhan,Xinyong Liu	61
18	Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP 2017 ·ACS Medicinal Chemistry Letters ·Dongwei Kang,Xiao Ding,Gaochan Wu,Zhipeng Huo,Zhongxia Zhou,Tong Zhao,Da Feng,Zhao Wang,Ye Tian,Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	29
19	Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants 2017 ·Journal of Medicinal Chemistry ·Dongwei Kang,Zengjun Fang,Boshi Huang,Xueyi Lu,Heng Zhang,Haoran Xu,Zhipeng Huo,Zhongxia Zhou,(unknown),(unknown),Gaochan Wu,Xiao Ding,Ye Tian,Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	84
20	Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel” 2017 ·Organic & Biomolecular Chemistry ·Zhongxia Zhou,Tao Liu,Dongwei Kang,Zhipeng Huo,Gaochan Wu,Dirk Daelemans,Erik De Clercq,Christophe Pannecouque,Peng Zhan,Xinyong Liu	26

About Gaochan Wu

Gaochan Wu is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (14 papers) and Click Chemistry and Applications (11 papers). The work is most often cited by research in Virology (356 citations), Infectious Diseases (439 citations) and Organic Chemistry (540 citations). Gaochan Wu has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Xinyong Liu, Dongwei Kang, Peng Zhan, Lanlan Jing, Erik De Clercq, Christophe Pannecouque, Xiangyi Jiang, Zhongxia Zhou, Xia Hao and Zhipeng Huo. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact